Molecular Oncology
Volume 3, Issue 1 , Pages 67-76, February 2009

HBx genotype D represses GSTP1 expression and increases the oxidative level and apoptosis in HepG2 cells

School of Chemical and Biomedical Engineering, Nanyang Technological University, 62 Nanyang Drive, Singapore 637459, Singapore

Received 17 September 2008; accepted 15 October 2008. published online 17 November 2008.

Abstract 

Epigenetics has been implicated in human cancer development. Epigenetic factors include HBx protein, which is able to induce hypermethylation and suppresses tumor suppressor genes. One of such tumor suppressor genes, GSTP1, shows reduced expression in many human cancers. Hypermethylation of GSTP1 is the most studied mechanism of its silence. In the present study, we reported that GSTP1 expression was completely depleted in HBV integrated HepG2.2.15 cells due to the hypermethylation in its promoter region. And it was HBx, especially HBx genotype D, that played the key role in repressing GSTP1 expression. Further functional studies like ROS assay and apoptosis detection were also used to confirm this repression. Our findings should facilitate the understanding of HBV and their influences on the epigenetic modulations for epigenetic tumorigenesis during HBV-mediated hepatocellular carcinogenesis.

Keywords: HBV, HBx, DNA methylation, GSTP1, HepG2, HepG2.2.15

Abbreviations: HBV, hepatitis B virus, HBx, hepatitis B virus X, HCC, hepatocellular carcinoma, GSTP1, glutathione S-transferase P1, ROS, reactive oxygen species, DNMT1, DNA methyltransferase 1, MEM, minimal essential medium, DMEM, Dulbecco's modified Eagle's medium, PBS, phosphate-buffered saline, HBsAg, HBV surface antigen, HBcAg, HBV core antigen, MSP, methylation-specific PCR, TBHP, tert-butyl hydroperoxide

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1574-7891(08)00128-2

doi:10.1016/j.molonc.2008.10.002

Molecular Oncology
Volume 3, Issue 1 , Pages 67-76, February 2009